Correlation Between CSL and Genmab AS
Can any of the company-specific risk be diversified away by investing in both CSL and Genmab AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CSL and Genmab AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CSL and Genmab AS, you can compare the effects of market volatilities on CSL and Genmab AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CSL with a short position of Genmab AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of CSL and Genmab AS.
Diversification Opportunities for CSL and Genmab AS
Very poor diversification
The 3 months correlation between CSL and Genmab is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding CSL and Genmab AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genmab AS and CSL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CSL are associated (or correlated) with Genmab AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genmab AS has no effect on the direction of CSL i.e., CSL and Genmab AS go up and down completely randomly.
Pair Corralation between CSL and Genmab AS
Assuming the 90 days horizon CSL is expected to generate 0.38 times more return on investment than Genmab AS. However, CSL is 2.6 times less risky than Genmab AS. It trades about -0.03 of its potential returns per unit of risk. Genmab AS is currently generating about -0.04 per unit of risk. If you would invest 9,292 in CSL on September 2, 2024 and sell it today you would lose (104.00) from holding CSL or give up 1.12% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
CSL vs. Genmab AS
Performance |
| Timeline |
| CSL |
| Genmab AS |
CSL and Genmab AS Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CSL and Genmab AS
The main advantage of trading using opposite CSL and Genmab AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CSL position performs unexpectedly, Genmab AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genmab AS will offset losses from the drop in Genmab AS's long position.The idea behind CSL and Genmab AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Genmab AS vs. Inhibikase Therapeutics | Genmab AS vs. Purple Biotech | Genmab AS vs. Synaptogenix | Genmab AS vs. Legend Biotech Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |